Japanese stocks still look cheap after Shinzo Abe's resignation
A period of uncertainty after Shinzo Abe's resignation could be a good chance to buy Japanese stocks at a good price.


Japan’s longest ever serving prime minister, Shinzo Abe, has resigned on health grounds. We’ve written about Abe and his three arrow reforms – bold fiscal policy , expansionary monetary policy and structural reform – many times over the years. It hasn’t worked out perfectly (what does?) but his leadership has seen Japan make real progress (in the structural reform bit at least).
It is hard to imagine these policies being enthusiastically reversed – particularly given that Abe’s successor will almost definitely come from the ruling LDP party. Very easy monetary policy and massive fiscal stimulus is now the global norm. That Japan was first into it is hardly evidence it will be the first to have a go at finding its way out (not everyone agrees by the way.
We would expect fiscal and monetary policy to stay pretty aggressive (the budget deficit may be obscene but the Bank of Japan will be keeping interest rates very low) and for all the attempts to improve corporate governance and so on to continue. Expect tweaks, but not much more.
Subscribe to MoneyWeek
Subscribe to MoneyWeek today and get your first six magazine issues absolutely FREE

Sign up to Money Morning
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
In the shorter term, Japan looks like it will have a reasonably strong third quarter – daily Covid cases are falling; restrictions are being relaxed; mobility is back up with online routing requests back at pre-pandemic levels (thanks in part to the domestic tourism “Go to Travel” campaign); and the government has announced that over 98% of households have received their ¥100,000 (£700) cash handout. Hopefully they will get out and spend it – retail spending rose 13% in June and new car registrations were up 20% in July, notes Capital Economics, so they are clearly in mood.
Industrial production also looks to be coming back nicely – Capital Economics has pencilled in a 5% rise in production in July and 6.5% fall in GDP over the full year (not bad under the circumstances), but given Japan’s strong corporate balance sheets, good virus control and lack of dependence on overseas tourism that might be pessimistic.
If the change at the top – and the scramble to replace Abe – means the market sells off properly (equities were down 1.6% at their worst today), I’ll be buying more Japan in my Sipp. Few markets are cheap in absolute terms at the moment but Japan remains relatively inexpensive on most measures (cyclically adjusted P/E ratio and dividend yield in particular) and offers the now unusual prospect of long term rises in the dividend payout ratios. A key number to remember is that in July this year 56% of Japan listed companies had net cash. Only 16% of those in the S&P 500 did. In this environment, most other things being equal, which would you rather hold?
Value investors looking at Japan, try the AVI Japan Opportunity Trust (LSE: AJOT). Growth-orientated investors might look at Baillie Gifford’s Japan Trust (LSE: BGFD).
Sign up for MoneyWeek's newsletters
Get the latest financial news, insights and expert analysis from our award-winning MoneyWeek team, to help you understand what really matters when it comes to your finances.
Cris Sholto Heaton is an investment analyst and writer who has been contributing to MoneyWeek since 2006 and was managing editor of the magazine between 2016 and 2018. He is especially interested in international investing, believing many investors still focus too much on their home markets and that it pays to take advantage of all the opportunities the world offers. He often writes about Asian equities, international income and global asset allocation.
Cris began his career in financial services consultancy at PwC and Lane Clark & Peacock, before an abrupt change of direction into oil, gas and energy at Petroleum Economist and Platts and subsequently into investment research and writing. In addition to his articles for MoneyWeek, he also works with a number of asset managers, consultancies and financial information providers.
He holds the Chartered Financial Analyst designation and the Investment Management Certificate, as well as degrees in finance and mathematics. He has also studied acting, film-making and photography, and strongly suspects that an awareness of what makes a compelling story is just as important for understanding markets as any amount of qualifications.
-
Hargreaves Lansdown slashes fees for ISA and SIPP investors - how does it compare to other providers?
Hargreaves Lansdown, the UK’s biggest investment platform, has dropped its fees by 40%, to their lowest ever level, for certain customers. Is it a good deal, and how does it compare to other providers?
By Ruth Emery
-
BP's 'long, painful decline' – and why next year could be even tougher
Opinion Long-suffering shareholders in oil giant BP have been pushing for change. It won’t come soon enough, says Matthew Lynn
By Matthew Lynn
-
BP's 'long, painful decline' – and why next year could be even tougher
Opinion Long-suffering shareholders in oil giant BP have been pushing for change. It won’t come soon enough, says Matthew Lynn
By Matthew Lynn
-
Investment trusts tap the profits in exotic and obscure global markets
Opinion Peter Walls, manager of the Unicorn Mastertrust fund, highlights three investment trusts as he shares where he'd put his money
By Peter Walls
-
Falling revenues and mounting debt spell trouble for Jumia Technologies
Struggling African e-commerce platform Jumia Technologies looks headed for the exit, says Dr Matthew Partridge.
By Dr Matthew Partridge
-
Next reports £1 billion in annual profits for the first time – what's next for the retailer?
Clothing retailer Next has become only the fourth member of its sector to surpass £1 billion in annual profits. What does this mean for the company's future?
By Dr Matthew Partridge
-
Best of British bargains: cash in on undervalued companies in the UK stock market
Opinion Michael Field, Chief Equity Market Strategist, EMEA, Morningstar, selects three attractive UK stocks where he'd put his money
By Michael Field
-
Building firm Keller presents low debt and ample scope for growth
Geotechnical contractor Keller, which supports vital global infrastructure, boasts rising profits and a cheap valuation
By Dr Mike Tubbs
-
PZ Cussons share price down 75% in last decade – why it's one to watch
Opinion Once-strong consumer-goods business PZ Cussons is out of favour with the market. That spells opportunity for investors, says Jamie Ward
By Jamie Ward
-
Cash in on the biotech sector with specialist trust BioPharma
Opinion BioPharma has an attractive niche in lending to asset-rich biotechnology companies
By Rupert Hargreaves